Fora Capital, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Fora Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $107,195 - $150,561	-2,654 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$51.77 - $66.18 $137,397 - $175,641	2,654 New	2,654 $151,000
Q3 2020 Nov 13, 2020	SELL	$43.8 - $58.16 $78,402 - $104,106	-1,790 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$37.05 - $65.03 $84,585 - $148,463	-2,283 Reduced 56.05%	1,790 $107 Million
Q1 2020 May 15, 2020	BUY	$33.63 - $69.4 $136,974 - $282,666	4,073 New	4,073 $167,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.